Today’s top gainers include the company Zoetis Inc. (NYSE:ZTS) which is in the industry Drugs – Generic, gaining -0.02% today. In the last week its performance is 2.23%, and 4.13% for the past quarter. Currently, Zoetis Inc., ZTS has a target price of 52.7, so today’s gain of -0.02% is a significant step towards its target price. The GAP today is therefore 0.08%.
Zoetis Inc. (NYSE:ZTS), has a market cap of 23549.91, and is based in USA. Insider ownership is at 0.01%, and institutional ownership is 95.10%.
At the current price of 47.45, it has a dividend yield of 0.80%, and its target price is 52.7. This is with a profit margin of 7.80%, and total debt/equity of 3.84. Zoetis Inc. (NYSE:ZTS) has a P/E of 62.68, as well as a forward P/E of 20.67.
With a current EPS of 0.76, and a forecasted EPS growth for next year at 22.91%,Zoetis Inc. (NYSE:ZTS) has had a EPS growth for the past five years at 25.10%. For the next five years EPS growth is projected to be 12.58%.
Performance for the year is -0.80%. Since its IPO date on 02/01/2013, the total performance to date is -0.35%.
Volume today for Zoetis Inc. (NYSE:ZTS), is 2008304, while its average volume is 3751.65. Whilst the total gain today was -0.02%, it did have a day high of -2.86%.
Volatility for this week has been at 1.71%, and 1.63% for the month. The 52-week low for Zoetis Inc., ZTS has been 26.80%, while the 52-week-high has reached -4.89%.
Looking at its return of investments, which is 5.70%, and its return on assets is 5.30%. Zoetis Inc. (NYSE:ZTS) has an operating margin of 13.40%. With a sales growth of 5.40% quarter over quarter. Bearing in mind that Zoetis Inc., ZTS is in the sector Healthcare, its long-term debt/equity is 3.83, and has a current ratio of 2.8 and 1.6 for quick ratio.
So what is the value of Zoetis Inc.? Well its PEG is 4.98, and the P/S is 4.88, along with a P/B of 20.28. Meanwhile it has a p/cash of 34.89.